Delving Into the Dialogue between Epigenetic Modifications and Immunometabolism in Cancer
Advanced Genetics · 2025-09 · 6 (3)
DOI: 10.1002/ggn2.202500034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Genetics, online erschienen am 05.09.2025. Verfasst von Xiaowen Xie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital Wuxi Medical Center Nanjin…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tumor immunometabolism and epigenetic modifications are intricately linked in reshaping the tumor microenvironment, with their crosstalk offering novel insights into cancer biology. Nutrient deprivation and metabolic byproducts drive metabolic reprogramming in immune cells, where metabolites act as epigenetic modulators to regulate immune‐related gene expression and influence immune cell activation, differentiation, and functional states. The cellular complexity, dynamic interactions, and spatiotemporal heterogeneity of the tumor microenvironment pose significant challenges to current studies. Emerging technologies such as single‐cell sequencing, spatial omics, and artificial intelligence provide powerful tools to address these complexities. This perspective discusses the crosstalk between tumor immunometabolism and epigenetic modifications, while also exploring how the emerging technologies may advance mechanistic insights and therapeutic innovation in this field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital Wuxi Medical Center Nanjing Medical University Wuxi 214023 China.
- Department of Lung Cancer Tianjin Lung Cancer Center National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Tianjin Medical University…
- Department of Oncology Zhujiang Hospital Southern Medical University Guangzhou 510282 China.
- Department of Interventional Radiology Zhongshan Hospital Shanghai Institute of Medical Imaging National Clinical Research Center of Interventional Medicine Fudan University Shanghai 200032 China.
ORCID-Profile: Wenjun Mao
Zitieren
APA
Xie, X., Liu, W., Zhang, P., Luo, P., Tang, B., & Mao, W. (2025). Delving Into the Dialogue between Epigenetic Modifications and Immunometabolism in Cancer. Advanced Genetics, 6(3). https://doi.org/10.1002/ggn2.202500034
Vancouver
Xie X, Liu W, Zhang P, Luo P, Tang B, Mao W. Delving Into the Dialogue between Epigenetic Modifications and Immunometabolism in Cancer. Advanced Genetics. 2025;6(3). doi:10.1002/ggn2.202500034
BibTeX
@article{Xie2025,
author = {Xie, Xiaowen and Liu, Weici and Zhang, Pengpeng and Luo, Peng and Tang, Bufu and Mao, Wenjun},
title = {Delving Into the Dialogue between Epigenetic Modifications and Immunometabolism in Cancer},
journal = {Advanced Genetics},
year = {2025},
volume = {6},
number = {3},
doi = {10.1002/ggn2.202500034}
}
EUVIMED